UPROSERTIB: 30 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
30
Total FAERS Reports
5 (16.7%)
Deaths Reported
26
Hospitalizations
30
As Primary/Secondary Suspect
3
Life-Threatening
First Report: 20100716 · Latest Report: 20161115
What Are the Most Common UPROSERTIB Side Effects?
#1 Most Reported
Dyspnoea
5 reports (16.7%)
#2 Most Reported
Respiratory failure
3 reports (10.0%)
#3 Most Reported
Diarrhoea
3 reports (10.0%)
All UPROSERTIB Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Dyspnoea | 5 | 16.7% | 1 | 5 |
Who Reports UPROSERTIB Side Effects? Age & Gender Data
Gender: 71.0% female, 29.0% male. Average age: 62.1 years. Most reports from: US. View detailed demographics →
Is UPROSERTIB Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2010 | 2 | 1 | 2 |
| 2013 | 3 | 0 | 3 |
| 2014 | 18 | 1 | 16 |
| 2015 | 4 | 3 | 3 |
| 2016 | 2 | 0 | 2 |
What Is UPROSERTIB Used For?
| Indication | Reports |
|---|---|
| Neoplasm | 9 |
Official FDA Label for UPROSERTIB
Official prescribing information from the FDA-approved drug label.